Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080342279> ?p ?o ?g. }
- W2080342279 endingPage "455" @default.
- W2080342279 startingPage "451" @default.
- W2080342279 abstract "In Brief Objectives: The objectives of this study are 1) to determine whether the future liver remnant will grow after portal vein embolization (PVE) in patients with colon cancer on concurrent chemotherapy and 2) to determine whether recovery after extended hepatectomy is improved after PVE. Purpose: Neoadjuvant chemotherapy followed by hepatic resection is an increasingly used therapeutic strategy for curative treatment for colorectal metastases. However, such chemotherapy may result in steatosis, liver damage, and compromised liver regeneration and recovery. This study aims to determine whether PVE can be used during neoadjuvant therapy to enhance growth of future residual liver and to improve postoperative recovery. Methods: From September 1999 to September 2004, 100 patients with colorectal metastases to the liver were subjected to PVE as preparation for extended hepatic resection, 43 of whom were embolized during neoadjuvant chemotherapy. Liver growth was examined by computed tomography volumetric analysis. Clinical outcomes of the 71 patients subsequently resected were compared with 100 consecutive patients subjected to extended resection without PVE (controls). Results: After a median wait of 30 ± 2 days after PVE, patients on neoadjuvant chemotherapy experienced a median contralateral (nonembolized) liver growth of 22% ± 3% compared with 26% ± 3% for those without chemotherapy (P = NS). The number of patients with <5% growth was also similar: 4 of 43 versus 6 of 57 (P = NS). Comparison of patients resected after PVE to a simultaneous cohort of 100 consecutive patients subjected to extended resection without prior PVE demonstrated a lower fresh frozen plasma requirement (P = 0.01), a lower peak bilirubin (P = 0.002), and a shorter length of stay (P = 0.03). Mortality was similar (0% vs. 2%). Conclusions: Liver growth occurs after PVE even when cytotoxic chemotherapy is administered. No major complications occurred with PVE. Patients requiring major hepatic resection should be considered for PVE during neoadjuvant chemotherapy to improve subsequent recovery after resection. Forty-three patients with colon cancer underwent portal vein embolization (PVE) during neoadjuvant chemotherapy and were compared with the 57 who did not receive chemotherapy between PVE and resection. At 1 month, the growth in the contralateral hemiliver in the chemotherapy group was 22% ± 3% compared with 26% ± 3% (NS) for those without. Compared with a similar cohort of 100 extended liver resections at the same center, the FFP requirement, peak bilirubin, and length of stay were significantly shorter in the PVE group." @default.
- W2080342279 created "2016-06-24" @default.
- W2080342279 creator A5005824918 @default.
- W2080342279 creator A5009465403 @default.
- W2080342279 creator A5010847388 @default.
- W2080342279 creator A5021772683 @default.
- W2080342279 creator A5042440032 @default.
- W2080342279 creator A5045514779 @default.
- W2080342279 creator A5057183711 @default.
- W2080342279 creator A5058825770 @default.
- W2080342279 creator A5068308443 @default.
- W2080342279 creator A5069644669 @default.
- W2080342279 creator A5078241870 @default.
- W2080342279 creator A5090827566 @default.
- W2080342279 date "2008-03-01" @default.
- W2080342279 modified "2023-10-18" @default.
- W2080342279 title "Combined Portal Vein Embolization and Neoadjuvant Chemotherapy As a Treatment Strategy for Resectable Hepatic Colorectal Metastases" @default.
- W2080342279 cites W1971409448 @default.
- W2080342279 cites W1985941484 @default.
- W2080342279 cites W2013906087 @default.
- W2080342279 cites W2029260840 @default.
- W2080342279 cites W2038268626 @default.
- W2080342279 cites W2048489304 @default.
- W2080342279 cites W2054265070 @default.
- W2080342279 cites W2066040529 @default.
- W2080342279 cites W2078345568 @default.
- W2080342279 cites W2079652621 @default.
- W2080342279 cites W2084466825 @default.
- W2080342279 cites W2084470612 @default.
- W2080342279 cites W2142564546 @default.
- W2080342279 cites W2148566563 @default.
- W2080342279 cites W2153454475 @default.
- W2080342279 cites W2157769714 @default.
- W2080342279 cites W2165941188 @default.
- W2080342279 cites W2314927739 @default.
- W2080342279 doi "https://doi.org/10.1097/sla.0b013e31815ed693" @default.
- W2080342279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18376189" @default.
- W2080342279 hasPublicationYear "2008" @default.
- W2080342279 type Work @default.
- W2080342279 sameAs 2080342279 @default.
- W2080342279 citedByCount "166" @default.
- W2080342279 countsByYear W20803422792012 @default.
- W2080342279 countsByYear W20803422792013 @default.
- W2080342279 countsByYear W20803422792014 @default.
- W2080342279 countsByYear W20803422792015 @default.
- W2080342279 countsByYear W20803422792016 @default.
- W2080342279 countsByYear W20803422792017 @default.
- W2080342279 countsByYear W20803422792018 @default.
- W2080342279 countsByYear W20803422792019 @default.
- W2080342279 countsByYear W20803422792020 @default.
- W2080342279 countsByYear W20803422792021 @default.
- W2080342279 countsByYear W20803422792022 @default.
- W2080342279 countsByYear W20803422792023 @default.
- W2080342279 crossrefType "journal-article" @default.
- W2080342279 hasAuthorship W2080342279A5005824918 @default.
- W2080342279 hasAuthorship W2080342279A5009465403 @default.
- W2080342279 hasAuthorship W2080342279A5010847388 @default.
- W2080342279 hasAuthorship W2080342279A5021772683 @default.
- W2080342279 hasAuthorship W2080342279A5042440032 @default.
- W2080342279 hasAuthorship W2080342279A5045514779 @default.
- W2080342279 hasAuthorship W2080342279A5057183711 @default.
- W2080342279 hasAuthorship W2080342279A5058825770 @default.
- W2080342279 hasAuthorship W2080342279A5068308443 @default.
- W2080342279 hasAuthorship W2080342279A5069644669 @default.
- W2080342279 hasAuthorship W2080342279A5078241870 @default.
- W2080342279 hasAuthorship W2080342279A5090827566 @default.
- W2080342279 hasConcept C121608353 @default.
- W2080342279 hasConcept C126322002 @default.
- W2080342279 hasConcept C126838900 @default.
- W2080342279 hasConcept C141071460 @default.
- W2080342279 hasConcept C159110652 @default.
- W2080342279 hasConcept C2776035437 @default.
- W2080342279 hasConcept C2776694085 @default.
- W2080342279 hasConcept C2776909242 @default.
- W2080342279 hasConcept C2778292576 @default.
- W2080342279 hasConcept C2910754948 @default.
- W2080342279 hasConcept C526805850 @default.
- W2080342279 hasConcept C530470458 @default.
- W2080342279 hasConcept C71924100 @default.
- W2080342279 hasConceptScore W2080342279C121608353 @default.
- W2080342279 hasConceptScore W2080342279C126322002 @default.
- W2080342279 hasConceptScore W2080342279C126838900 @default.
- W2080342279 hasConceptScore W2080342279C141071460 @default.
- W2080342279 hasConceptScore W2080342279C159110652 @default.
- W2080342279 hasConceptScore W2080342279C2776035437 @default.
- W2080342279 hasConceptScore W2080342279C2776694085 @default.
- W2080342279 hasConceptScore W2080342279C2776909242 @default.
- W2080342279 hasConceptScore W2080342279C2778292576 @default.
- W2080342279 hasConceptScore W2080342279C2910754948 @default.
- W2080342279 hasConceptScore W2080342279C526805850 @default.
- W2080342279 hasConceptScore W2080342279C530470458 @default.
- W2080342279 hasConceptScore W2080342279C71924100 @default.
- W2080342279 hasIssue "3" @default.
- W2080342279 hasLocation W20803422791 @default.
- W2080342279 hasLocation W20803422792 @default.
- W2080342279 hasOpenAccess W2080342279 @default.
- W2080342279 hasPrimaryLocation W20803422791 @default.
- W2080342279 hasRelatedWork W2003011688 @default.